The impact of global diabetes prevention efforts has been modest despite the promise of
landmark diabetes prevention trials nearly twenty years ago. While national and regional …

The International Diabetes Federation estimates that 415 million adults worldwide now have
diabetes and 318 million have impaired glucose tolerance. These numbers are expected to …

Abstract Purpose of Review This article highlights foundational evidence, translation studies,
and current research behind type 2 diabetes prevention efforts worldwide, with focus on high …

Background The evidence base for the prevention of type 2 diabetes mellitus (T2DM) has
progressed rapidly from efficacy trials to real-world translational studies and practical …

Abstract Purpose of Review Type 2 diabetes is common, burdensome, and preventable.
Landmark trials such as the Diabetes Prevention Program (DPP) demonstrated that …

Type 2 diabetes and other noncommunicable diseases are a growing public health
challenge globally. An estimated 285 million people, corresponding to 6.4% of the world's …

To address the public health and economic burden of type 2 diabetes, the Centers for
Disease Control and Prevention (CDC) began dissemination of the National Diabetes …

The steady increase in the incidence of type 2 diabetes is a major challenge to health care
systems and health policy development. 1 Diabetes leads to significantly reduced quality of …

CONTEXT: Type 2 diabetes is a major contributor to disease burden globally. A number of
systematic reviews support the efficacy of lifestyle interventions in preventing Type 2 …

Diabetes is a costly disease affecting 387 million individuals globally and 28 million in the
United States. Its precursor, prediabetes, affects 316 and 86 million individuals globally and …